Biologics License Application for Subcutaneous Formulation of “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

(NASDAQ:BIIB), TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of “LEQEMBI(R)” (brand name in China: […]

Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore

New facility delivers 24/7 threat monitoring, rapid response and AI-driven cybersecurity for industrial operations across Asia Pacific. Rockwell Automation, the world’s largest company dedicated to industrial automation and digital transformation, has launched a Security Operations Center (SOC) in Singapore, enhancing cybersecurity resilience for industrial customers across Asia Pacific. The new facility is part of Rockwell

Biologics License Application for Subcutaneous Formulation of “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

Biologics License Application for Subcutaneous Formulation of “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China GlobeNewswire February 09, 2026 TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO:

DreamTech Unveils Neural4D-2.5: Introducing the “Native 3D” Architecture for High-Fidelity AIGC

San Francisco, California–(Newsfile Corp. – February 8, 2026) – DreamTech has officially announced the launch of Neural4D-2.5, its new generation foundational model for 3D AIGC (Artificial Intelligence Generated Content). By introducing the innovative Native 3D Attribute Grid architecture, DreamTech aims to enhance the quality and accessibility of high-fidelity 3D assets for creators worldwide. Neural4D-2.5 represents

Peter Pru, Founder of Option Sellers School, Launches ArkPicks, an AI-Powered Options Screening Tool for Busy Investors

Philadelphia, PA, Feb. 08, 2026 (GLOBE NEWSWIRE) — Peter Pru, Founder of Option Sellers School, has launched ArkPicks, an AI-powered options research platform designed to help systematic options sellers reduce time spent on manual research and decision preparation. The platform consolidates technical analysis, AI-generated news summaries, liquidity data, earnings tracking, and trade calculations into a

Peter Pru, Founder of Option Sellers School, Launches ArkPicks, an AI-Powered Options Screening Tool for Busy Investors

Peter Pru, Founder of Option Sellers School, Launches ArkPicks, an AI-Powered Options Screening Tool for Busy Investors GlobeNewswire February 09, 2026 Philadelphia, PA, Feb. 08, 2026 (GLOBE NEWSWIRE) — Peter Pru, Founder of Option Sellers School, has launched ArkPicks, an AI-powered options research platform designed to help systematic options sellers reduce time spent on manual

Luckin Coffee Unveils Its 30,000th Store – the Origin Flagship: A New Chapter for Quality Upgrade and Shared Value Creation

Leading retail coffee chain Luckin Coffee (“Luckin” or “the brand”, OTC:LKNCY) announced the official inauguration of its 30,000th store, the first Origin Flagship, in Shenzhen. Tied to the core theme of Global Origins, this landmark opening signifies a strategic evolution for the brand: while solidifying its industry-leading scale, Luckin is elevating its focus on professionalism

FFIV DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important February 17 Deadline in Securities Class Action – FFIV

New York, New York–(Newsfile Corp. – February 8, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the “Class Period”), of the important February 17, 2026 lead plaintiff deadline. SO WHAT: If

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Beyond Meat, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BYND

New York, New York–(Newsfile Corp. – February 8, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the “Class Period”), of the important March 24, 2026 lead plaintiff deadline. SO WHAT:

Abaxx Exchange to Extend Trading Access Through TMX Trayport's Joule Platform

London, United Kingdom and Singapore, Singapore–(Newsfile Corp. – February 8, 2026) – Abaxx Commodity Exchange and Clearinghouse (Abaxx Exchange), together with TMX Trayport, a wholly owned subsidiary of TMX Group, today announced that Abaxx Exchange will extend trading access through TMX Trayport’s Joule trading platform, with connectivity expected before the end of the first quarter

Scroll to Top